860674 | Sphinganine (d20:0)
D-erythro-sphinganine (C20 base)

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Sphinganine (d20:0)
D-erythro-sphinganine (C20 base)
CAS Registry Number is a Registered Trademark of the American Chemical Society
110749
Jakobi K, Beyer S, Koch A, Thomas D, Schwalm S, Zeuzem S, Pfeilschifter J, Grammatikos G. Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro. Int J Mol Sci. 2020 Mar 31;21(7):2409. doi: 10.3390/ijms21072409. PMID: 32244391; PMCID: PMC7177910.
PubMed ID: 32244391Vutukuri R, Koch A, Trautmann S, Schreiber Y, Thomas D, Mayser F, Meyer Zu Heringdorf D, Pfeilschifter J, Pfeilschifter W, Brunkhorst R. S1P d20:1, an endogenous modulator of S1P d18:1/S1P2 -dependent signaling. FASEB J. 2020 Jan 15:10.1096/fj.201902391R. doi: 10.1096/fj.201902391R. Epub ahead of print. PMID: 31944406.
PubMed ID: 31944406- Certificate of Analysis (Lot No. 860674P-5MG-A-010 and 6091PHA010)
- Certificate of Analysis (Lot No. 860674P-5MG-C-010 and 6091PHC010)
- Certificate of Analysis (Lot No. 860674P-5MG-D-010 and 6091PHD010)
- Certificate of Analysis (Lot No. 860674P-5MG-B-010 and 6091PHB010)
- Certificate of Analysis (Lot No. 860674P-5MG-A-011 and 6091PHA011)
- Certificate of Analysis (Lot No. 860674P-5MG-B-011 and 6091PHB011)